echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > Inventory of key approved drugs in May 2015

    Inventory of key approved drugs in May 2015

    • Last Update: 2015-07-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    For 14 chemicals approved as new drugs, by dosage form, the most common is APIs (7 drugs), followed by injections (3 drugs), tablets (2 drugs), in addition to 1 capsule and 1 granule Among these new drugs, some are exclusive in varieties and some are exclusive in dosage forms In addition, there are many varieties that are the first listed in domestic enterprises Here is an introduction to the key drugs in May: exclusive or the first product in China: arginine glutamate raw material and injection approval number: gyzz h20150031, gyzz h20150032; manufacturer: Liaoning hisic Pharmaceutical Co., Ltd.; specification: 200ml: 20g; treatment area: digestive tract and metabolism; Note: it is the first and only one in China; 2 Approval number of raw materials and cream of Halometasone: gyzz h20150036, gyzz h20153118; manufacturer: Chongqing Huabang Pharmaceutical Co., Ltd.; specification: 0.05%; treatment field: Dermatology medicine; Note: at present, this product is only imported and listed in China, Chongqing Huabang is the first enterprise to list this product in China; exclusive dosage form: 1 Approval number of tilidine hydrochloride tablets: gyzz h20150037, gyzz h20150038; manufacturer: Hebei Aoxing Group Pharmaceutical Co., Ltd.; specification: 50mg, 100mg; treatment field: bone and muscle system; Note: at present, there is only one enterprise in China to list the tiridine hydrochloride oral liquid, and the tiridine hydrochloride tablets are the exclusive listed dosage forms, and there are two specifications listed, so there are more options In addition, it is found that the product belongs to controlled drugs; 2 Zuoxitirizin hydrochloride granules approval No.: gyzz h20150042; manufacturer: Hainan Kangzhi Pharmaceutical Co., Ltd.; specification: 2.5mg; treatment field: respiratory system; Note: at present, levocetirizine hydrochloride tablets, dispersible tablets, oral liquids and oral drops are listed in China, the most dosage forms are tablets, and granules are listed for the first time; 3 Approval number of flupentixol-t-melitracen capsule: gyzz h20150043; manufacturer: Chengdu Beite Pharmaceutical Co., Ltd.; specification: flupentixol-t-0.5mg and melitracen 10mg; Treatment field: nervous system; remarks: in recent half a year, three domestic enterprises have successively listed flupentixomil tablets, including one in this month, while only one in Chengdu Beite has been listed in China at present; other worthy of attention: 1 Approval number of oxcarbazepine tablets: gyzz h20153124; manufacturer: Beijing Sihuan pharmaceutical Co., Ltd; Specification: 0.15g; treatment field: nervous system; remarks: at present, there are two domestic enterprises listing oxcarbazepine tablets, one of which is Sihuan pharmaceutical, but the specifications are all 0.3g This time, Sihuan pharmaceutical listed 0.15g oxcarbazepine tablets, which is the first time for domestic enterprises However, Novartis has three specifications for import and listing, and one 0.6g specification is not listed in domestic enterprises at present; 2 Approval document No of iodophor injection: gyzz h20153103; manufacturer: Beijing Beilu Pharmaceutical Co., Ltd.; specification: 50ml: 18.5g (I); treatment field: Miscellaneous (contrast agent); Note: at present, there is only one enterprise listed in China, but this enterprise has six specifications, and Beilu pharmaceutical only has one specification this time Although it breaks the exclusive market in China, it is still unknown how much market it can occupy; 3 Approval number of recombinant human follicle stimulating hormone for injection: gyzz s20150007; manufacturer: Changchun Jinsai Pharmaceutical Co., Ltd; Specification: 5.5ug (75iu) / bottle; treatment field: hormone system medication of non sex hormone and insulin; note: This product is a biological product of Changchun Kinsey imitating Merck xuelanuo Previously, only Merck xuelanuo was imported and listed in China In 2014, the sales volume of the sample hospital was more than 260 million, and now domestic manufacturers have a share Attachment: Traditional Chinese Medicine
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.